James P. Tursi

2017 - Aralez Pharmaceuticals

In 2017, James P. Tursi earned a total compensation of $1.1M as Chief Medical Officer at Aralez Pharmaceuticals, a 49% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$171,032
Option Awards$86,859
Salary$412,000
Stock Awards$433,565
Other$10,280
Total$1,113,736

Tursi received $433.6K in stock awards, accounting for 39% of the total pay in 2017.

Tursi also received $171K in non-equity incentive plan, $86.9K in option awards, $412K in salary and $10.3K in other compensation.

Rankings

In 2017, James P. Tursi's compensation ranked 8,465th out of 14,666 executives tracked by ExecPay. In other words, Tursi earned more than 42.3% of executives.

ClassificationRankingPercentile
All
8,465
out of 14,666
42nd
Division
Manufacturing
3,205
out of 5,768
44th
Major group
Chemicals And Allied Products
1,064
out of 2,074
49th
Industry group
Drugs
840
out of 1,730
51st
Industry
Pharmaceutical Preparations
656
out of 1,329
51st
Source: SEC filing on May 18, 2018.

Tursi's colleagues

We found five more compensation records of executives who worked with James P. Tursi at Aralez Pharmaceuticals in 2017.

2017

Adrian Adams

Aralez Pharmaceuticals

Chief Executive Officer

2017

Scott Charles

Aralez Pharmaceuticals

Chief Financial Officer

2017

Andrew Koven

Aralez Pharmaceuticals

President and Chief Business Officer

2017

Mark Glickman

Aralez Pharmaceuticals

Former Chief Commercial Officer

2017

Michael Kaseta

Aralez Pharmaceuticals

Chief Financial Officer

News

You may also like